Liberate Medical Completes Enrollment of 250-Patient PREVENT Pivotal Trial Evaluating VentFree® Respiratory Muscle Stimulator Liberate Medical, a clinical-stage medical device company developing breakthrough neuromuscular electrical stimulation (NMES) technology for mechanically ventilated ICU patients, today announced the completion of enrollment in…
Innovate 32 Partners with Crestview Dental and Cedar Street Family Dentistry, Continuing Momentum in East Tennessee Innovate 32 a growth-oriented dental services organization, today announced new partnerships with Crestview Dental and Cedar Street Family Dentistry, two highly respected general dentistry…
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results Amylyx Pharmaceuticals, Inc. today reported financial and business results for the fourth quarter and full year ended December 31, 2025. 2025 was a year of meaningful advancement for Amylyx’s…
Royalty Pharma Names Kenneth Sun as Senior Vice President and Head of Asia, Strengthening Its Global Expansion Strategy and Regional Presence Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of…
Genentech Announces Positive Phase III Results for Fenebrutinib in RMS, Paving the Way for Regulatory Submission Why is the search for effective treatments for multiple sclerosis (MS) more urgent than ever? Genentech, a member of the Roche Group, has announced…
Positive Phase 3 Trial Results Signal New Standard of Care for Bladder Cancer Patients Is the current standard of care for muscle-invasive bladder cancer (MIBC) about to change? Pfizer Inc. and Astellas Pharma Inc. have announced groundbreaking results from the…
Organon Presents Data on VTAMA Cream’s Impact on Sleep at AAAAI 2026 Annual Meeting How can we address the significant sleep disturbances that affect children with atopic dermatitis and their families? Organon a global healthcare company dedicated to delivering impactful…
Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global leader in NAD+ science and healthy aging, has announced the…
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments, LP, are joining forces to address this question and more.…
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in San Mateo, CA, is making significant strides in this area.…
Leadership Transition Signals Ascensia’s Commitment to Long-Term Growth and Innovation Why is the leadership transition at Ascensia Diabetes Care significant for the global healthcare industry? Ascensia Diabetes Care, a global leader in diabetes management solutions, has announced the appointment of…
Biotech Leader OmniAb, Inc. to Showcase Cutting-Edge Antibody Discovery Technology In the rapidly evolving landscape of biotechnology, where innovation and precision are paramount, OmniAb, Inc. stands out as a leader in discovery research technology. The company, known for its advanced…